INBX Inhibrx Biosciences, Inc.
$109.27▼ -1.93%
Healthcare
Other
After hours
$109.27▲ +0.00%
Sep 11, 7:30 PM ET
Volume 210.8K
Avg Volume (10D) 441.7K
Key Metrics & Fundamentals
Market Cap
$1.61B
P/E Ratio
–
Div Yield
–%
52W Range
26.19 - 155.29
% vs 50 MA
10.88%
% vs 200 MA
21.97%
RSI-14
50.3
MACD Histogram
-1.7600
Beta (1Y vs SPY)
2.52
Free Cash Flow
-$29.92M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$30.43M
COGS
–
Operating Exp
$32.15M
Operating Income
-$32.15M
EBIT
-$32.15M
Pretax Income
-$36.65M
Net Income
-$36.65M
EPS (Diluted)
-2.34
Price & Volume History
Loading chart…
Recent News
Inhibrx Shares Rise After Positive Phase 2 Head and Neck Cancer Data
InvestorsHub · Sep 8, 2026 12:51 PM
Inhibrx Biosciences Says Cancer Combination Therapy Shows Improved Response in Phase 2 Study
MT Newswires · Sep 8, 2026 12:50 PM
Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study
PR Newswire · Sep 8, 2026 11:30 AM
Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study
PR Newswire · Sep 4, 2026 8:00 PM
Inhibrx Reports Second Quarter 2026 Financial Results
PR Newswire · Aug 13, 2026 8:00 PM
Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million
PR Newswire · Jul 16, 2026 1:00 PM
Are You Looking for a Top Momentum Pick? Why Inhibrx Biosciences, Inc. (INBX) is a Great Choice
Zacks · Jul 9, 2026 4:00 PM
Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
PR Newswire · Jun 15, 2026 1:15 PM
Financial Overview - Income Statement
Quarterly
Jun 2025
See INBX's money flow as a full page
Social Sentiment
No Reddit posts found for INBX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.